Laboratory Corporation of America Holdings LH, known as LabCorp, recently launched the Labcorp Clinical Decision Support (CDS) interpretative test report for its Stinging Insect Component-Specific IgE ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) reported Q2 CY2025 results , with sales up 9.5% year on year to $3.53 billion. Its non-GAAP profit of $4.35 per share was 4.5% above analysts’ ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its non-GAAP profit of $4.18 per share ...

Labcorp (NYSE:LH) on Wednesday announced the latest addition to its Alzheimer's testing portfolio: The pTau217 test, designed to identify phosphorylated tau 217 (pTau217), a key blood-based biomarker ...

Labcorp (NYSE:LH) posted its fourth consecutive quarterly revenue decline on Thursday, estimating up to a 90% decline in its COVID testing revenue this year amid the waning pandemic impact. However, ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the testing & diagnostics services industry, including Labcorp (NYSE:LH) and its ...

Laboratory Corporation of America Holdings or LabCorp LH recently announced the availability of therascreen KRAS PCR Mutation Analysis -- a companion diagnostic (CDx) to spot patients with non-small ...